Searched for
GLOBAL PHARMACY HUB
Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
Lenskart, Ola’s Q4 scorecards; Visa maze for laid-off techiesLenskart has posted a sharp jump in its March-quarter revenue even as profit dipped marginally. This and more in today’s ETtech Top 5.
These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
Lord’s Mark among few global players to win HIV self-test approval, exports from June 2026Lord's Mark Industries Ltd. has secured Central Licensing Authority approval for its LordsMed HIV 1&2 Self Test, becoming one of nine globa...
India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
Pharmaceutical logistics in demand as war rattles supply chainsMedicines are vital but useless if lost or spoiled. Pharmaceutical logistics ensures their safe delivery. DHL's Florstadt campus near Frank...
Budget 2026: Govt to upgrade allied health institutions, train 1 lakh professionalsThe government plans to boost healthcare by upgrading allied health institutions and training one lakh professionals over five years. Careg...
Obesity treatment drugs to be new growth engine for pharma industry: Sun PharmaIndia, known for its generic drug industry, is rapidly transforming into a major hub for global weight management industry, amid rapid incr...
Amgen to invest $200 million in India site, CEO saysAmgen will invest $200 million in its new technology centre in Hyderabad, India, this year, with plans for further investments. The centre,...
India's pharma sector robust, met both local and global demand during pandemic: Mansukh Mandaviya"India played a phenomenal role in meeting the requirements of not just its domestic but needs of many others under unprecedented circumsta...
Chinese cities give out free fever drugs as COVID flaresChina's policy U-turn caught a fragile health system unprepared, with hospitals scrambling for beds and blood, pharmacies for drugs and aut...
Saveo raises $4.5 million in funding at $50 million valuationThe latest round valued the B2B startup at $50 million, it said in a statement. The company had earlier raised $4 million in seed round in ...
DCGI claims India on course to become global drugs hubSpeaking at the Indian Drug Manufacturers' Association (IDMA) Annual Conclave, Somani said, "We are getting the applications of the investi...
Recurring nightmareIn today's ETtech Morning Dispatch newsletter: BillDesk is expected to enjoy a virtual monopoly in processing recurring payments, RBI has t...
Best time to invest in pharma, medical device sector: DV Sadananda GowdaThe Indian pharma sector, currently valued at USD 40 billion, has the potential to become a global pharmacy hub in the coming years, the Ch...
'Atmanirbhar' to make India a nerve centre of global supply chain, it's not inward looking: MEA officialSpeaking at a webinar organised by Calcutta Chamber of Commerce, Rahul Chhabra, secretary (economic relations) to the MEA said that the gov...
Health-tech startup Aermed secures seed fundingAermed, is an online pharmacy store that allows you to order medicines online that get delivered at your doorstep within 24 hours.
India could become a global pharmacy hub: Dilip ShanghviThere is a focus on the request of industry to migrate towards global practices, which is what will lead to product quality in India, says ...
Make In India: Pharma entrepreneurs urge industry to address compliance issuesShanghvi said companies need to move beyond being mere generic players and look to innovate to capture the potential $800-billion pharmaceu...